Protein Summary
May participate in diverse steps of neurogenesis. Inhibits the processing of pro-matrix metalloproteinase 2 (MMP-2) by MT1-MMP and MT3-MMP. May interfere with tumor invasion. This gene encodes a member of a novel family of calcium-binding proteoglycan proteins that contain thyroglobulin type-1 and Kazal-like domains. The encoded protein and may play a role in adult T-cell leukemia by inhibiting the activity of membrane-type matrix metalloproteinases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Oct 2011]
- ENST00000357154
- ENSP00000349677
- ENSG00000196104
- ENST00000357545
- ENSP00000350153
- ENST00000421836
- ENSP00000411344
- ENST00000502330
- ENSP00000423606
- ENST00000504953
- ENSP00000425570
- ENST00000506886
- ENSP00000420920
- ENST00000510741
- ENSP00000426716
- ENST00000511269
- ENSP00000425502
- ENST00000511531
- ENSP00000423421
- ENST00000512648
- ENSP00000426177
- ENST00000512681
- ENSP00000426318
- ENST00000541354
- ENSP00000444789
- TICN3
- TES-3
- TICN3
- HSAJ1454
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
trait | 0.75 | ||
disease perturbation | 0.74 | ||
microRNA | 0.72 | ||
PubMedID | 0.66 | ||
molecular function | 0.63 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 10.32 (req: < 5)
Gene RIFs: 5 (req: <= 3)
Antibodies: 125 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 10.32 (req: >= 5)
Gene RIFs: 5 (req: > 3)
Antibodies: 125 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 8
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligand: 0
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0